Search PDMR transactions

Notifier
Name of person with notification obligation
Elisabeth Pålsson
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Thomas Pålsson
Position
Chief Financial Officer (CFO)
Initial notification
No
Amendment
Yes
Details of amendment
Lösen minskning för TR
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Stayble Therapeutics AB
Issuer´s LEI code
549300WD23DE1US21868
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA Stayble Therapeutics AB BTA SE0019912874 Acquisition 4,280 Quantity 1.78 SEK 12/04/2023 Outside a trading venue
Subscription right/Unit right Stayble Therapeutics AB TR SE0019912866 Exercise decrease 3,000 Quantity 0.00 SEK 12/04/2023 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Stayble Therapeutics AB BTA SE0019912874 Acquisition 12/04/2023 Outside a trading venue 4,280 (Quantity) 1.78 SEK
Stayble Therapeutics AB TR SE0019912866 Exercise decrease 12/04/2023 Outside a trading venue 3,000 (Quantity) 0.00 SEK
<< Back